Archive: 23/10/2014

Scientists to use tiny particles to fight big diseases

Physicians will tell you: They are not winning the war on ovarian cancer. But FIU researchers are crafting a new weapon for that battle. A group of scientists have combined medicine and advanced nanotechnological engineering ...

Added benefit of vedolizumab is not proven

Vedolizumab (trade name Entyvio) has been approved since May 2014 for patients with moderately to severely active Crohn disease or ulcerative colitis. In an early benefit assessment pursuant to the Act on the Reform of the ...

page 6 from 10